These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21253612)

  • 1. Elimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules.
    Wen X; Abe T; Kukihara H; Taguwa S; Mori Y; Tani H; Kato N; Suzuki T; Tatsumi M; Moriishi K; Matsuura Y
    PLoS One; 2011 Jan; 6(1):e15967. PubMed ID: 21253612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
    Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
    Erickson AK; Seiwert S; Gale M
    Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV).
    Aly HH; Oshiumi H; Shime H; Matsumoto M; Wakita T; Shimotohno K; Seya T
    PLoS One; 2011; 6(6):e21284. PubMed ID: 21731692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway.
    Liu WL; Yang HC; Su WC; Wang CC; Chen HL; Wang HY; Huang WH; Chen DS; Lai MY
    PLoS One; 2012; 7(9):e43824. PubMed ID: 22962590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
    Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
    J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.
    Liu JP; Ye L; Wang X; Li JL; Ho WZ
    Transpl Infect Dis; 2011 Feb; 13(1):24-32. PubMed ID: 21040279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex.
    Lee HC; Narayanan S; Park SJ; Seong SY; Hahn YS
    J Biol Chem; 2014 Feb; 289(8):5310-9. PubMed ID: 24385435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro.
    Castet V; Fournier C; Soulier A; Brillet R; Coste J; Larrey D; Dhumeaux D; Maurel P; Pawlotsky JM
    J Virol; 2002 Aug; 76(16):8189-99. PubMed ID: 12134024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric mice.
    Uchida T; Hiraga N; Imamura M; Yoshimi S; Kan H; Miyaki E; Tsuge M; Abe H; Hayes CN; Aikata H; Ishida Y; Tateno C; Ellis JD; Chayama K
    Virus Res; 2016 Feb; 213():62-68. PubMed ID: 26569595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.
    Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M
    Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-λ1 contributes to its anti-HCV activity in human hepatoma cells.
    Li X; Li Y; Fang S; Su J; Jiang J; Liang B; Huang J; Zhou B; Zang N; Ho W; Li J; Li Y; Chen H; Ye L; Liang H
    Antiviral Res; 2017 Apr; 140():83-94. PubMed ID: 28131804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine withdrawal enhances hepatitis C virus replicon expression.
    Wang CQ; Li Y; Douglas SD; Wang X; Metzger DS; Zhang T; Ho WZ
    Am J Pathol; 2005 Nov; 167(5):1333-40. PubMed ID: 16251417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.